Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection

International Journal of Gastrointestinal Cancer

Volumn 28, Issue 1, 2000, Pages 33-41

  Niedergethmann, Marco ^a   Hildenbrand, Ralf ^a   Wolf, Georg ^a   Verbeke, Caroline S ^a   Richter, Axel ^a   Post, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Cathepsin B; Cathepsin L; Microvessel density; Pancreatic cancer; Prognostic factors; Vascular endothelial growth factor

Indexed keywords

EID: 0002912546     PISSN: 15373649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Warshaw AL, del Castillo F. Pancreatic carcinoma. N Engl J Med 1992; 326: 455.
2. Trede M, Schwall G, Saeger HD. Survival after pancreaticoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990; 211: 447-458.
3. Trede M. Surgical Options for Pancreatic Cancer, in Surgery of the Pancreas, Trede M, Carter DC, eds. Churchill Livingston, New York, NY, 1997, pp. 471-481.
4. Yeo CJ, Cameron JL. Prognostic factors in ductal pan creatic cancer. Langenbecks Arch Surg 1998; 383: 129-133.
5. Ellenrieder V, Adler G, Gress TM. Invasion and metastasis in pancreatic cancer. Ann Oncol 1999; 10(suppl) 46-50.
6. Lemoine NR. Molecular advances in pancreatic cancer. Digestion 1997; 58: 550-556.
7. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
8. Weidner N, Semple JP, Welch WR, Folkman N. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
9. Maeda K, Chung YS, Takatuka S, Ogawa Y, Onoda N, Sawada T, el al. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995; 72: 319-323.
10. Ferrara N, Houck KA, Jakeman L, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47: 211-218.
11. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastases. Clin Exp Met 1992; 10: 145-155.
12. Kuliawat R, Klumperman J, Ludwig T, Arvan P. Differential sorting of lysosomal enzymes out of the regulated secretory pathway in pancreatic β-cells. J Cell Biol 1997; 137: 595-608.
13. Leto G, Tumminello FM, Pizzolanti G, Montalto G, Soresi M, Carroccio A, et al. Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis. Pancreas 1997; 14: 22-27.
14. Ohta T, Terada T, Nagakawa T. Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesion. Br J Cancer 1994; 69: 152-156.
15. Yamaguchi N, Chung SM, Shiroeda O, Imanishi J. Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP. Cancer Res. 1990; 50: 658-663.
16. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL. Cathepsin D and prognosis in breast cancer. N Engl J Med 1990; 322: 297-302.
17. Breslow NE. Analysis of survival data under the proportional hazards model. Int. Stat Rev. 1975; 43: 45-58.
18. Wilcoxon F, Katti S K, Wilcox RA. Critical values and probability levels for the Wilcoxon Rank Sum Test and the Wilcoxon signed rank test. Pearl River, NY, Lederle Laboratories, 1963.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457,458.
20. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
21. Dugan MC and Sarkar FH. Current concepts in pancreatic cancer: symposium summary. Pancreas 1998; 17: 325-333.
22. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111-115.
23. Fidler IJ and Ellis LM. The implications of angiogenesis for the biology and therapy of cancermetastases. Cell 1994; 79: 185-188.
24. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, micro vascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
25. Kuehn R, Lelkes PI, Bloechle C, Niendorf A, Izbicki JR. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas 1999; 18: 96-103.
26. Boehle AS, Kalthoff H. Molecular mechanisms of tumor metastasis and angiogenesis. Langenbecks Arch Surg 1999; 384: 133-140.
27. Siemeister G, Martiny-Baron G, Marme D. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities. Cancer Metastasis Rev 1998; 17: 241-248.
28. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM. Hypoxia-induced paracrine regulation of vascular endothelian growth factor. J Clin Invest 1996; 97: 469-476.
29. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirawasa S, Sasa zuki T, Kerbel RS. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 1995; 55: 4575-4580.
30. Detmar M, Brown LF, Claffey KB, Yeo KT, Kocher O, Jackman RW, et al. Overexpression of vascular permeability/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 1994; 180: 1141-1146.
31. Ikeda N, Adachi M, Taki T, Hashida H, Sho M, Nakajima Y, et al. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999; 79: 1553-1563.
32. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757-1763.
33. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS. Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumor growth in vivo. Nature 1993; 362: 4262-4267.
34. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M. Angiostatin: a novel angiogenesis inhibitor that mediates the supression of metatases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
35. Ramakrishnan S, Olson TA, Bautch VL, Mohanraj D. Vascular endothelial factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res 1996; 56:1324-1330.
36. Fujimoto K, Hosotani R, Wada M, Lee JU, Koshiba T, Miyamoto Y, et al. Expression of two angiogenic factors, VEGF and PDEGF in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer 1989; 34:1439-1447.
37. Sloane BF, Dunn JR, Honn KV. Lysosomal Cathepsin B: correlation with metastatic potential. Science 1981; 212: 1151-1153.
38. Im B, Kominami E, Grube D, Uchiyama Y. Immunhistocytocemical localization of cathepsin B and H in human pancreatic endocrinecells and insulinoma cells. Histochem 1998; 93: 111-118.